No Data
Jupiter Neurosciences, Inc. Announces Deferred Repayment Commencement Date to April 1, 2026, Maintaining Core Financing Terms
Jupiter Neurosciences Selected as B2i Digital Featured Company
Jupiter Announces $35M ParaFi Investment, Deal to Settle in JupUSD
Enveric Biosciences ENVB Direct Offering; Jupiter Neurosciences JUNS GLP-1 Strategy
Express News | Jupiter Neurosciences Shares Are Trading Lower. The Company Announced a Strategic Initiative to Support Individuals Using GLP-1-based Weight Loss Therapies Through Its Nugevia Consumer Longevity Product Line
Express News | Jupiter Neurosciences Inc - Announces Strategic Initiative for GLP-1 Users